Pharmacokinetics and Pharmacodynamics Practice Questions

Q: A patient reaches a steady state level of lithium that produces toxic side effects. If he decides to discontinue his medication, how long would it take for his lithium blood levels to reach 25% of his original steady state levels, assuming a half-life of 22 hours for lithium?

44 hours. ### Explanation **1. Understanding the Correct Answer (D: 44 hours)** The elimination of drugs following **first-order kinetics** (like Lithium) occurs at a constant fractional rate. The time required for the plasma concentration of a drug to reduce by 50% is defined as its **half-life ($t_{1/2}$)**. To reach 25% of the steady-state concentration, the drug must undergo **two half-lives**: * **After 1st half-life:** Concentration drops to 50% of the original level. * **After 2nd half-life:** Concentration drops to 25% (half of 50%). Given the $t_{1/2}$ of Lithium is 22 hours: $2 \times 22 \text{ hours} = \mathbf{44 \text{ hours}}$. **2. Analysis of Incorrect Options** * **Option A (11 hours):** This represents half of a half-life ($0.5 \times t_{1/2}$), which does not correspond to a standard elimination milestone. * **Option B (22 hours):** This is exactly one half-life. At this point, the concentration would be 50%, not 25%. * **Option C (33 hours):** This represents 1.5 half-lives. At this stage, the concentration would be approximately 35.3%. **3. Clinical Pearls for NEET-PG** * **Steady State Rule:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration ($C_{ss}$) and the same amount of time to completely eliminate a drug from the body (>95% washout). * **Lithium Kinetics:** Lithium is handled by the kidneys similarly to sodium. Dehydration, NSAIDs, and Thiazide diuretics can decrease its clearance, leading to toxicity. * **Therapeutic Index:** Lithium has a **narrow therapeutic index** (0.6–1.2 mEq/L). Toxicity typically manifests at levels >1.5 mEq/L with symptoms like coarse tremors, ataxia, and seizures. * **First-Order vs. Zero-Order:** Most drugs follow first-order kinetics (constant percentage per unit time). Only a few follow zero-order (constant amount per unit time), such as **P**henytoin, **A**lcohol, and **W**arfarin/High-dose **A**spirin (Mnemonic: **PAW**).

Q: A drug has 80% absorption and a hepatic extraction ratio of 0.4. Calculate the bioavailability of the drug?

48%. ### Explanation **1. Understanding the Correct Answer (C: 48%)** Bioavailability ($F$) is the fraction of an administered dose that reaches the systemic circulation in an unchanged form. When a drug is given orally, it must first be absorbed from the gut and then pass through the liver (first-pass metabolism). The formula for systemic bioavailability is: **$F = f \times (1 - ER)$** * **$f$ (Absorption):** 80% or 0.8 * **$ER$ (Extraction Ratio):** 0.4 * **$(1 - ER)$ (Hepatic Escape Fraction):** This represents the fraction of the drug that escapes hepatic metabolism. Here, $1 - 0.4 = 0.6$ (or 60%). **Calculation:** $F = 0.8 \times 0.6 = 0.48$ $0.48 \times 100 = \mathbf{48\%}$ **2. Why Other Options are Incorrect** * **A (12%):** This is a mathematical error, likely from multiplying half of the extraction ratio by a fraction of the absorption. * **B (32%):** This occurs if you incorrectly multiply the absorption (0.8) by the extraction ratio (0.4) instead of the escape fraction. This represents the amount metabolized, not the amount reaching circulation. * **D (64%):** This value is obtained if one ignores the extraction ratio and applies a different coefficient, or incorrectly calculates $0.8 \times 0.8$. **3. NEET-PG High-Yield Clinical Pearls** * **Definition:** Bioavailability of an **Intravenous (IV)** dose is always **100% (F=1)**. * **First-Pass Effect:** Drugs with a high Hepatic Extraction Ratio (e.g., **Lidocaine, Propranolol, Nitroglycerin**) have low oral bioavailability and are often given via non-enteral routes. * **Area Under the Curve (AUC):** Bioavailability is calculated by comparing the AUC of oral administration to the AUC of IV administration: $F = \frac{AUC_{oral}}{AUC_{IV}}$. * **Clinical Significance:** If a drug’s ER is >0.7, its bioavailability will be low, and small changes in hepatic enzyme activity can lead to significant changes in plasma drug levels.

Q: Which of the following acts on nuclear receptors?

Thyroxine. **Explanation:** The correct answer is **Thyroxine (D)**. Receptors are classified based on their location and mechanism of action. **Nuclear receptors** are intracellular receptors that act as ligand-activated transcription factors. To reach these receptors, a drug must be lipid-soluble to cross the cell membrane. * **Thyroxine (T4/T3):** Although thyroid hormones are amino acid derivatives, they enter the cell via specific transporters and bind to receptors located directly on the **nucleus**. Once bound, they alter gene transcription, leading to the synthesis of new proteins. Other examples of drugs acting on intracellular/nuclear receptors include Steroids (Glucocorticoids, Mineralocorticoids, Sex hormones), Vitamin A, and Vitamin D. **Why other options are incorrect:** * **GABA (A):** Acts on **Ionotropic receptors** (GABA-A is a ligand-gated chloride channel) or Metabotropic receptors (GABA-B is G-protein coupled). * **Insulin (B):** Acts on **Enzyme-linked receptors** (specifically, Receptor Tyrosine Kinase) located on the cell membrane. * **Alpha-1 receptor (C):** This is a **G-Protein Coupled Receptor (GPCR)**, specifically the Gq subtype, which works via the IP3-DAG second messenger pathway. **High-Yield NEET-PG Pearls:** 1. **Fastest acting receptors:** Ion channels (milliseconds), e.g., Nicotinic ACh receptors. 2. **Slowest acting receptors:** Nuclear receptors (hours to days), as they require gene transcription and protein synthesis. 3. **Mnemonic for Cytoplasmic vs. Nuclear:** Most steroids bind in the **C**ytoplasm (except Estrogen/Thyroid), while **T**hyroid, **E**strogen, **V**itamin A & D bind directly in the **N**ucleus (**TEN**).

Q: Which of the following statements about biotransformation is untrue?

More fat-soluble metabolites are formed.. ### Explanation **Biotransformation** (Drug Metabolism) is the chemical alteration of a drug in the body, primarily occurring in the liver. Its fundamental biological purpose is to convert **lipid-soluble (non-polar)** compounds into **water-soluble (polar)** compounds to facilitate excretion by the kidneys. #### Why Option C is Untrue (The Correct Answer) Metabolism aims to decrease lipid solubility. If metabolites were more fat-soluble, they would be reabsorbed by the renal tubules back into the systemic circulation, leading to drug accumulation and toxicity. Therefore, the formation of more fat-soluble metabolites is incorrect. #### Analysis of Other Options * **A & B: Inactive and Active metabolites are formed:** Most drugs are inactivated by metabolism (e.g., Paracetamol). However, some drugs are converted into **active metabolites** (e.g., Diazepam to Oxazepam) or are administered as **Prodrugs** (e.g., Enalapril to Enalaprilat), where metabolism is required for activation. * **D: More water-soluble metabolites are formed:** This is the primary goal of Phase I (Functionalization) and Phase II (Conjugation) reactions. Increasing polarity ensures the drug can be easily excreted in urine or bile. #### NEET-PG High-Yield Pearls * **Phase I Reactions:** Include Oxidation (most common), Reduction, and Hydrolysis. These primarily involve the **Cytochrome P450** enzyme system. * **Phase II Reactions:** Include Glucuronidation (most common), Acetylation, and Methylation. These usually result in total inactivation. * **Exception to the Rule:** Morphine-6-glucuronide is a rare example of a Phase II metabolite that is *more* active than the parent drug. * **First-Pass Metabolism:** Drugs with high first-pass metabolism (e.g., Nitroglycerin, Lidocaine) have low oral bioavailability.

Q: Which of the following drugs has the least oral bioavailability?

d-tubocurarine. **Explanation:** The correct answer is **d-tubocurarine (Option A)**. **1. Why d-tubocurarine is correct:** Bioavailability is the fraction of an administered drug that reaches the systemic circulation in an unchanged form. **d-tubocurarine** is a quaternary ammonium compound. Due to its strong positive charge, it is highly ionized at all physiological pH levels. Highly ionized drugs are **lipid-insoluble**, meaning they cannot cross the lipid bilayer of the gastrointestinal tract. Consequently, its oral bioavailability is nearly **zero**, necessitating intravenous administration for its effect as a neuromuscular blocker. **2. Why the other options are incorrect:** * **Morphine (B):** While morphine undergoes significant **first-pass metabolism** in the liver (reducing its bioavailability to ~25-30%), it is still absorbed from the gut and can be administered orally for chronic pain management. * **Ampicillin (C):** This is an acid-stable penicillin. Although its absorption is incomplete and can be decreased by food, it has a bioavailability of approximately 30-50%, making it effective via the oral route. * **Phenytoin (D):** This antiepileptic drug has high oral bioavailability (approx. 70-90%), though it exhibits slow and variable absorption. **3. Clinical Pearls for NEET-PG:** * **Quaternary Ammonium Compounds:** Drugs like d-tubocurarine, neostigmine, and ipratropium are permanently charged; they do not cross the GI tract or the Blood-Brain Barrier (BBB). * **First-Pass Effect:** High first-pass metabolism (e.g., Nitroglycerin, Lidocaine, Morphine) is a common reason for low bioavailability, but **poor lipid solubility** (e.g., Aminoglycosides, d-tubocurarine) results in the *least* oral absorption. * **Bioavailability (F):** For IV administration, F = 100% (or 1). For all other routes, F < 1.

Q: The time required to reach the steady state after a dosage regimen depends on which of the following?

Half-life of the drug. ### Explanation **1. Why the Correct Answer is Right (Half-life of the drug):** The concept of **Steady State** refers to the condition where the rate of drug elimination equals the rate of drug administration. In clinical pharmacokinetics, the time taken to reach this state is determined solely by the **elimination half-life ($t_{1/2}$)** of the drug. * It takes approximately **4 to 5 half-lives** to reach steady state (94% at 4 half-lives, 97% at 5 half-lives). * This rule applies regardless of the dose or the frequency of administration, as the rate of accumulation is a function of the drug's inherent clearance rate. **2. Why the Other Options are Incorrect:** * **Route of Administration (A):** This affects the *bioavailability* and the *speed* at which the initial peak concentration is reached, but it does not change the time required to achieve a stable equilibrium in the plasma. * **Dose Interval (C) & Dosage (D):** While these factors determine the **plateau concentration level** (i.e., how high or low the steady-state concentration will be), they do not influence the **time** taken to get there. Whether you give a large dose or a small dose, it will still take 4–5 half-lives to stabilize. **3. Clinical Pearls for NEET-PG:** * **Loading Dose:** If a rapid therapeutic effect is needed (e.g., Lidocaine in arrhythmias), a loading dose is given to bypass the 4–5 half-life delay. However, it does *not* reach a true steady state faster; it simply reaches the target concentration sooner. * **Washout Period:** Similarly, it takes 4–5 half-lives for a drug to be completely eliminated from the body after stopping the regimen. * **Formula:** $Steady State \approx 4.3 \times t_{1/2}$. * **Rule of Thumb:** For any drug following first-order kinetics, the time to steady state is independent of the dose.

Question 1

A patient reaches a steady state level of lithium that produces toxic side effects. If he decides to discontinue his medication, how long would it take for his lithium blood levels to reach 25% of his original steady state levels, assuming a half-life of 22 hours for lithium?

Accepted Answer

44 hours

Answer

11 hours

Answer

22 hours

Answer

33 hours

Question 2

What is true about plasma half-life?

Accepted Answer

Half-life remains constant for drugs eliminated by first-order kinetics

Answer

Is the same as bioavailability

Answer

It is directly proportional to clearance

Answer

It is inversely proportional to volume of distribution

Question 3

A drug has 80% absorption and a hepatic extraction ratio of 0.4. Calculate the bioavailability of the drug?

Accepted Answer

48%

Answer

12%

Answer

32%

Answer

64%

Question 4

Which of the following acts on nuclear receptors?

Accepted Answer

Thyroxine

Answer

GABA

Answer

Insulin

Answer

Alpha-1 receptor

Question 5

Which pathological state alters the volume of distribution of many drugs?

Accepted Answer

Congestive heart failure

Answer

Septicemia

Answer

Duodenal ulcers

Answer

Hypertension

Question 6

Which of the following terms best describes a drug that blocks the action of adrenaline at its receptors by occupying those receptors without activating them?

Accepted Answer

Pharmacologic antagonist

Answer

Non-competitive antagonist

Answer

Physiologic antagonist

Answer

Chemical antagonist

Question 7

Which of the following statements about biotransformation is untrue?

Accepted Answer

More fat-soluble metabolites are formed.

Answer

Inactive metabolites are formed.

Answer

Active metabolites are formed.

Answer

More water-soluble metabolites are formed.

Question 8

Which of the following drugs has the least oral bioavailability?

Accepted Answer

d-tubocurarine

Answer

Morphine

Answer

Ampicillin

Answer

Phenytoin

Question 9

The time required to reach the steady state after a dosage regimen depends on which of the following?

Accepted Answer

Half-life of the drug

Answer

Route of Administration

Answer

Dose interval

Answer

Dosage of the drug

Question 10

In drug metabolism, what is the primary role of the hepatic cytochrome P-450 system?

Accepted Answer

Mediating Phase I reactions such as hydrolysis, oxidation, and reduction.

Answer

Mediating Phase II reactions such as conjugation and synthesis.

Answer

Mediating both Phase I and Phase II reactions.

Answer

Converting hydrophilic metabolites into lipophilic metabolites.

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?